| Literature DB >> 33287389 |
Valéria Cataneli Pereira1,2, Luiza Pinheiro-Hubinger1, Adilson de Oliveira1, Danilo Flávio Moraes Riboli1, Katheryne Benini Martins1, Letícia Calixto Romero1, Maria de Lourdes Ribeiro de Souza da Cunha1.
Abstract
The ability of Staphylococcus epidermidis to produce virulence factors, such as biofilm, added to its increased resistance to antimicrobials can cause infections that are difficult to treat. Many staphylococcal virulence factors are under the control of the accessory gene regulator (agr). The objective of this study was to establish the agr locus and susceptibility of biofilm-producing S. epidermidis specimens to antimicrobial agents, through PCR reactions, reverse transcription polymerase chain reaction (RT-PCR), and the determination of minimum inhibitory concentration (MIC), and to analyze the clonal profile of 300 strains isolated from blood culture specimens from inpatients at a University Hospital in Brazil, over a 20-year period by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) techniques. The ica operon expression was shown in 83.6% strains, bhp gene in 11.5%, and aap gene in 32.8%. Oxacillin resistance was detected in 90.1%, while 4.9% showed tigecycline resistance, and intermediate resistance to quinupristin/dalfopristin was identified in 0.4%. Clonal profile determination showed 11 clusters, with the ST2 type determined as the major cluster. The S. epidermidis biofilm producer demonstrated a predominance of agr I locus, oxacillin resistance, and SCCmec III as well as the potential dissemination of pathogenic clones in hospital settings over long periods.Entities:
Keywords: ST2; agr locus; antimicrobial resistance; biofilm; oxacillin resistance
Mesh:
Substances:
Year: 2020 PMID: 33287389 PMCID: PMC7729762 DOI: 10.3390/molecules25235715
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Distribution of genes involved in the formation of Biofilm in Coagulase-negative Staphylococci (CoNS) species.
| Species |
|
|
|
| Operon |
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | N | % | N | % | N | % | |
|
| 119 | 96.8 | 144 | 87.3 | 181 | 81.5 | 179 | 75.8 | 105 | 98.1 | 34 | 91.9 | 103 | 99.0 |
|
| 0 | 0.0 | 10 | 6.1 | 13 | 5.9 | 23 | 9.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
|
| 3 | 2.4 | 7 | 4.2 | 17 | 7.7 | 17 | 7.2 | 1 | 0.9 | 1 | 2.7 | 1 | 1.0 |
|
| 1 | 0.8 | 3 | 1.8 | 7 | 3.2 | 6 | 2.5 | 1 | 0.9 | 0 | 0.0 | 0 | 0.0 |
|
| 0 | 0.0 | 0 | 0.0 | 2 | 0.9 | 7 | 3.0 | 0 | 0.0 | 1 | 2.7 | 0 | 0.0 |
|
| 0 | 0.0 | 1 | 0.6 | 2 | 0.9 | 4 | 1.7 | 0 | 0.0 | 1 | 2.7 | 0 | 0.0 |
N: number of samples; %: percentage of samples.
Figure 1Correlation between adherence and expression of the detected genes.
Relationship of genes related to biofilm production and detection of accessory gene regulator (agr) locus in Staphylococcus epidermidis positive by the reverse transcription polymerase chain reaction (RT-PCR) technique.
| Locus | ||||
|---|---|---|---|---|
| N | I | II | Not Detected | |
| Operon | 34 | 28 (45.9%) | 4 (6.5%) | 2 (3.3%) |
|
| 4 | 0 (0.0%) | 4 (6.5%) | 0 (0.0%) |
|
| 6 | 4 (6.6%) | 2 (3.3%) | 0 (0.0%) |
| Operon | 3 | 3 (4.9%) | 0 (0.0%) | 0 (0.0%) |
| Operon | 14 | 12 (19.7%) | 2 (3.3%) | 0 (0.0%) |
N = number of samples.
Distribution of the agr locus, mecA gene, and Staphylococcal chromosomal cassette mec (SCCmec) in S. epidermidis positive by the RT-PCR technique.
|
| SCC | ||||
|---|---|---|---|---|---|
| I | III | IV | Untyped | ||
| Operon | 33 (54%) | 3 (5.5%) | 22 (40%) | 8 (14.5%) | 0 (0.0%) |
| 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| 6 (9.8%) | 1 (1.8%) | 3 (5.5%) | 2 (3.6%) | 1 (1.8%) | |
| Operon | 3 (4.9%) | 0 (0.0%) | 0 (0.0%) | 3 (5.5%) | 0 (0.0%) |
| Operon | 13 (21.3%) | 1 (1.8%) | 12 (21.8%) | 1 (1.8%) | 0 (0.0%) |
n = number of samples.
Minimum inhibitory concentration (MIC) of antimicrobials (mg/mL), range of MIC (mg/mL), and percentage of resistant CoNS.
| Antimicrobial | Breakpoint | MIC50 | MIC90 | Variation | Resistance |
|---|---|---|---|---|---|
| Oxacillin | ≥0.5 | >256 | >256 | 0.047 to >256 | 83.6% |
| Vancomycin | ≥32 | 1.5 | 2 | 0.125 to 2 | 0 |
| Linezolid | ≥8 | 0.25 | 0.38 | 0.094 to 1 | 0 |
| Daptomycin | >1 | 0.125 | 0.19 | 0.019 to 0.5 | 0 |
| Quinupristin/dalfopristin | ≥4 | 0.19 | 0.5 | 0.094 to 2 | 0 |
| Tigecycline | >5 | 0.125 | 0.25 | 0.016 to 0.75 | 4.9% |
MIC50: Minimum antimicrobial inhibitory concentration to inhibit 50% of samples; MIC90: Minimum antimicrobial inhibitory concentration to inhibit 90% of samples.
Figure 2Dendrogram generated by the Dice/UPGMA (Bionumerics Applied Maths) analysis of Staphylococcus epidermidis biofilm producers isolated from 1990 to 2009, indicating the presence (+) or absence of (−) operon ica expression, bhp and aap genes, and carrying of the SCCmec and accessory gene regulator (agr) locus.
Oligonucleotides used in PCR techniques for genotypic identification, mecA gene, biofilm and SCCmec type.
| Primer | Nucleotide Sequences (5′ to 3′) | Pb | Products | References |
|---|---|---|---|---|
|
| GCTGCAACCAAGAAACAACC | 1022 | [ | |
|
| CGTGTATTCATAATATGCTTCGATT | |||
|
| TATGCAAGCCAAGCACTTGT | 453 |
| |
|
| GTGCGAAAGCCGATAACAAT | |||
|
| CCTTGGCTAGTACTACACCTTC | 615 |
| |
|
| GTGCTTGGCTTGCATAAACA | |||
|
| GAAGTCGTAACAAGG | - | 16S | [ |
|
| CAAGGCATCCACCGT | 23S | ||
|
| CCTATAAGACTGGGATAACTTCGGG | 791 | RNAr 16S | [ |
|
| CTTTGAGTTTCAACCTTGCGGTCG | |||
|
| TCTCTTGCAGGAGCAATCAA | 187 | IcaA | [ |
|
| TCAGGCACTAACATCCAGCA | |||
|
| CTGATCAAGAATTTAAATCACAAA | 302 | IcaB | |
|
| AAAGTCCCATAAGCCTGTTT | |||
|
| TAACTTTAGGCGCATATGTTT | 400 | IcaC | |
|
| TTCCAGTTAGGCTGGTATTG | |||
|
| ATGGTCAAGCCCAGACAGAG | 198 | IcaD | |
|
| CGTGTTTTCAACATTTAATGCAA | |||
|
| ATGAAAAATAAACAAGGATTTC | 1300 | Bhp | |
|
| GCCTAAGCTAGATAATGTTTG | |||
|
| ATGGGCAAACGTAGACAAG | 1100 | Aap | |
|
| ACCGTAAAAATCGTAATTATCTC | |||
|
| AAAATCGATGGTAAAGGTTGG | 533 | PBP2a | [ |
|
| AGTTCTGCAGTACCGGATTTG | |||
| DCS F2 | CATCCTATGATAGCTTGGTC | 342 | SCC | [ |
| DCS R1 | CTAAATCATAGCCATGACCG | |||
| CIF2 F2 | TTCGAGTTGCTGGATGAAGAAGG | 495 | SCC | |
| CIF2 R2 | ATTTACCACAAGGACTACCAGC | |||
| KDP F1 | AATCATCTGCCATTGGTGATGC | 284 | SCC | |
| KDP R1 | CGAATGAAGTGAAAGAAAGTGG | |||
| RIF4 F3 | GTGATTGTTCGAGATATGTGG | 243 | SCC | |
| RIF4 R9 | CGCTTTATCTGTATCTATCGC | |||
| arcC-Up | TTGATTCACCAGCGCGTATTGTC | 456 | Carbamate kinase | [ |
| arcC-Dn | AGGTATCTGCTTCAATCAGCG | |||
| aroE-Up | ATCGGAAATCCTATTTCACATTC | 456 | Chiquimate dehydrogenase | |
| aroE-Dn | GGTGTTGTATTAATAACGATATC | |||
| aroE-Up | CTAGGAACTGCAATCTTAATCC | 465 | Glycerol kinase | |
| aroE-Dn | TGGTAAAATCGCATGTCCAATTC | |||
| gmk-Up | ATCGTTTTATCGGGACCATC | 429 | Guanylate kinase | |
| gmk-Dn | TCATTAACTACAACGTAATCGTA | |||
| pta-Up | GTTAAAATCGTATTACCTGAAGG | 474 | Phosphate acetyltransferase | |
| pta-Dn | GACCCTTTTGTTGAAAAGCTTAA | |||
| tpi-Up | TCGTTCATTCTGAACGTCGTGAA | 402 | Triose-phosphate isomerase | |
| tpi-Dn | TTTGCACCTTCTAACAATTGTAC | |||
| yqiL-Up | CAGCATACAGGACACCTATTGGC | 516 | Acetylcoenzyme A acetyl transferase | |
| yqiL-Dn | CGTTGAGGAATCGATACTGGAAC |